|
General Information
|
|
|
Product
|
FXIIIA Peptide Multi-epitope
|
|
Description
|
Antigenic Blocking Peptide Blood coagulation factor XIII a subunit Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Multi-epitope synthetic peptides were used: amino acid range 1-50 and 700-732 A mixture of synthetic peptides used for FXIIIA-101AP and FXIIIA-112AP.
|
|
Accession #
|
GenBank: AAA52415.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
| Determinant |
Multi-epitope |
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P00488
|
|
Overview
|
Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.
|
|
Molecular Function
|
Metal ion binding; Protein-glutamine gamma-glutamyltransferase activity
|
|
Subcellular Location
|
Cytoplasm. Secreted
|
|
Structure
|
Tetramer of two A chains and two B chains.
|
|
Alternative Nomenclature
|
Coagulation factor XIII A chain antibody
F13A antibody
Factor XIIIA antibody
Fibrin stabilizing factor, A subunit antibody
Fibrinoligase antibody
FSF, A subunit antibody
TGase antibody
Transglutaminase A chain antibody
Transglutaminase. plasma antibody
|
| |
|
Factor XIIIa Antibody
FXIIIA Antibody FITC
FXIIIA Antibody BIOTIN
FXIIIA Positive Control
